期刊文献+

糖尿病大血管病变的防治策略:从强化降糖到协调平衡 被引量:9

Management strategy of diabetic macrovascular disease: From intensive glycemic control to harmonious equipoise
原文传递
导出
摘要 糖尿病大血管病的致病因素复杂。虽然糖尿病与动脉粥样硬化性心血管病关系密切,但两者发病机制有所区别。近年的临床试验表明仅强化降糖治疗难以减少心血管事件,必须结合降压和调脂等综合干预措施。要有效防止糖尿病对大血管的进行性损害,必须全面评估其血管病变的特征及危险性大小,干预得越早和越及时,就越有助于阻断高血糖诱发的代谢记忆与血管并发症,干预策略应注重危险因素的全面控制、治疗方法的协调平衡及个体化。 Etiology of diabetic macrovascular disease is complex. Although diabetes is closely associated with atherosclerotic cardiovascular diseases ( ASCVD ), their pathogeneses are different. Recent clinical trails showed that multiplex intervention including anti-hyperglycemia in combination with lipids adjusting and blood pressure lowering procedures significantly reduced the events of ASCVD, but intensive gljcemic control alone did not. To prevent the ongoing diabetic macrovascular lesion, comprehensive evaluation of macrovascular damage and risks is very important. In addition, early treatment of hyperglycemia will blockade the hyperglycemia-induced metabolic memory and ameliorate vascular complications. Management of diabetic macrovascular disease should emphasize the strategy of simultaneously modifying all of the risk factors, harmonious equipoise of intervention and tailoring treatment.
作者 祝之明
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2009年第4期361-365,共5页 Chinese Journal of Endocrinology and Metabolism
关键词 糖尿病 大血管病变 干预策略 Diabetes mellitus Macrovascular diseases Management strategy
  • 相关文献

参考文献52

  • 1Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation, 1999,100 : 1134-1146.
  • 2Ceoper-DeHoff RM, Pacanowski MA, Pepine CJ. Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J Am Coil Cardiol, 2009, 53:S28-S34.
  • 3潘长玉.2型糖尿病强化降糖治疗与预防心血管病的思考和策略[J].中华内分泌代谢杂志,2009,25(1):1-4. 被引量:21
  • 4Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care,2009,32 : 187-192.
  • 5Holman RR, Paul SK,Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008,359:1577-1589.
  • 6Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet, 2009,373 : 1765-1772.
  • 7Gaede P, Lund-Andersen H, Parring HH. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med, 2008, 358 : 580-591.
  • 8谭姣容,陈宇红,徐敏,黄韵,毕宇芳,宁光,李小英.正常高值血压对2型糖尿病动脉粥样硬化的影响[J].中华内分泌代谢杂志,2009,25(4):370-373. 被引量:6
  • 9顾卫琼,张翼飞,洪洁,陈瑛,张钰,张豫文,李小英,宁光.2型糖尿病一级亲与非一级亲冠状动脉病变程度的比较[J].中华内分泌代谢杂志,2009,25(4):374-377. 被引量:2
  • 10张丹丹,安力春,母义明,孟俊华,邓斌,李小囡,李忠辉,窦京涛,陆菊明,潘长玉.2型糖尿病颈动脉及下肢动脉硬化与冠状动脉疾病相关[J].中华内分泌代谢杂志,2009,25(4):366-369. 被引量:28

二级参考文献131

共引文献107

同被引文献92

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部